Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) FCF Margin (2021 - 2026)

Core Scientific has reported FCF Margin over the past 6 years, most recently at 120.92% for Q1 2026.

  • Quarterly results put FCF Margin at 120.92% for Q1 2026, up 4132.0% from a year ago — trailing twelve months through Mar 2026 was 129.98% (down 8053.0% YoY), and the annual figure for FY2025 was 141.29%, down 13110.0%.
  • FCF Margin reached 120.92% in Q1 2026 per CORZ's latest filing, up from 152.62% in the prior quarter.
  • Across five years, FCF Margin topped out at 147.07% in Q4 2022 and bottomed at 162.24% in Q1 2025.
  • Median FCF Margin over the past 5 years was 15.75% (2024), compared with a mean of 38.71%.
  • The largest annual shift saw FCF Margin surged 17581bps in 2022 before it plummeted -17456bps in 2025.
  • Over 5 years, FCF Margin stood at 147.07% in 2022, then tumbled by -95bps to 7.09% in 2023, then tumbled by -322bps to 15.75% in 2024, then tumbled by -869bps to 152.62% in 2025, then rose by 21bps to 120.92% in 2026.
  • Business Quant data shows FCF Margin for CORZ at 120.92% in Q1 2026, 152.62% in Q4 2025, and 138.97% in Q3 2025.